Demand for specialist expertise in formulation development and compound manufacturing is continuing to rise

Pharmaceuticals are shifting towards developing modified release dosage forms

In line with this, the pharmaceutical industry is seeing a shift to develop modified release dosage forms that can deliver more therapeutic value and better outcomes for different groups, such as pediatric and geriatric patients.

Bora’s Business Development Department spoke to Pharmaceutical Technology Europe to discuss some of the key challenges impacting the pharmaceutical development pipeline and the importance of a continued patient-centric approach.

For the full article, see:

Please share this content with others who may benefit from it.
You may also be interested in